Annual EBITDA
$761.20M$11.20M+1.49%
Summary
- Current Value
- As of today, WST annual EBITDA is $761.20M, up +1.49% on
- Historical Performance
- WST annual EBITDA is down -13.90% over the past 3 years, up +44.14% over the past 5 years
- All-Time High Comparison
- WST annual EBITDA is currently -13.90% below its historical high of $884.10M set on
- 3-Year Low Comparison
- WST annual EBITDA is +1.49% above its 3-year low of $750.00M reached on
- Sector Comparison
- WST annual EBITDA is higher than 92.13% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $761.20M | +1.5% | -13.9% | +44.1% | +324.8% | |
| Quarterly EBITDA | $223.30M | +5.7% | +15.8% | +48.1% | +456.9% | |
| TTM EBITDA | $808.00M | +7.5% | -8.3% | +51.0% | +349.9% | |
| Price | $231.09 | +3.1% | -26.5% | -15.7% | +1009.9% | |
| PE Ratio | 34.02 | +1.5% | -16.4% | -43.3% | +53.6% | |
| Annual Revenue | $3.07B | +6.3% | +6.6% | +43.2% | +178.3% | |
| Annual EPS | $6.79 | +1.6% | -12.1% | +48.7% | +663.0% | |
| $589.80M | -0.8% | -22.8% | +40.8% | +456.4% | ||
| Annual Net Income | $493.70M | +0.2% | -15.7% | +42.6% | +656.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $884.10M | N/A | -13.9% |
| 5Y | $884.10M | -13.9% | |
| All | $884.10M | -13.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $750.00M | +1.5% | |
| 5Y | $528.10M | N/A | +44.1% |
| All | $23.45M | +3145.9% |
EBITDA History
FAQ
What is the current annual EBITDA of WST?
As of today, WST annual EBITDA is $761.20M
What is 1-year change in WST annual EBITDA?
WST annual EBITDA is up +1.49% year-over-year
What is 3-year change in WST annual EBITDA?
WST annual EBITDA is down -13.90% over the past 3 years
How far is WST annual EBITDA from its all-time high?
WST annual EBITDA is currently -13.90% below its historical high of $884.10M set on December 31, 2022
How does WST annual EBITDA rank versus sector peers?
WST annual EBITDA is higher than 92.13% of companies in Healthcare sector
When is WST next annual earnings release?
As of today, the next annual earnings release for WST has not been scheduled
Quarterly EBITDA
$223.30M$6.60M+3.05%
Summary
- Current Value
- As of today, WST quarterly EBITDA is $223.30M, up +3.05% on
- Historical Performance
- WST quarterly EBITDA is up +5.68% year-over-year, up +15.76% over the past 3 years
- All-Time High Comparison
- WST quarterly EBITDA is currently -12.09% below its historical high of $254.00M set on
- 3-Year Low Comparison
- WST quarterly EBITDA is +37.33% above its 3-year low of $162.60M reached on
- Sector Comparison
- WST quarterly EBITDA is higher than 92.23% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $223.30M | +3.0% | +5.7% | +15.8% | +48.1% | |
| Annual EBITDA | $761.20M | – | +1.5% | -13.9% | +44.1% | |
| TTM EBITDA | $808.00M | +1.5% | +7.5% | -8.3% | +51.0% | |
| Price | $231.09 | -13.6% | +3.1% | -26.5% | -15.7% | |
| PE Ratio | 34.02 | -14.2% | +1.5% | -16.4% | -43.3% | |
| Quarterly Revenue | $806.00M | +0.2% | +7.7% | +13.8% | +38.9% | |
| Quarterly EPS | $1.82 | -5.8% | +2.4% | +33.4% | +40.5% | |
| $157.10M | -9.6% | -7.9% | -2.9% | +28.4% | ||
| Quarterly Net Income | $132.10M | -5.6% | +1.5% | +28.3% | +34.3% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $223.30M | at high | |
| 3Y | $226.80M | -1.5% | |
| 5Y | $254.00M | -12.1% | |
| All | $254.00M | -12.1% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $168.40M | +32.6% | |
| 3Y | $162.60M | +37.3% | |
| 5Y | $150.80M | N/A | +48.1% |
| All | -$192.90M | +215.8% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of WST?
As of today, WST quarterly EBITDA is $223.30M
What is WST quarterly EBITDA most recent change?
WST quarterly EBITDA was up +3.05% on December 31, 2025
What is 1-year change in WST quarterly EBITDA?
WST quarterly EBITDA is up +5.68% year-over-year
How far is WST quarterly EBITDA from its all-time high?
WST quarterly EBITDA is currently -12.09% below its historical high of $254.00M set on June 30, 2022
How does WST quarterly EBITDA rank versus sector peers?
WST quarterly EBITDA is higher than 92.23% of companies in Healthcare sector
When is WST next earnings release?
The next earnings release for WST is on
TTM EBITDA
$808.00M$12.00M+1.51%
Summary
- Current Value
- As of today, WST TTM EBITDA is $808.00M, up +1.51% on
- Historical Performance
- WST TTM EBITDA is up +7.50% year-over-year, down -8.25% over the past 3 years
- All-Time High Comparison
- WST TTM EBITDA is currently -10.53% below its historical high of $903.10M set on
- 3-Year Low Comparison
- WST TTM EBITDA is +8.19% above its 3-year low of $746.80M reached on
- Sector Comparison
- WST TTM EBITDA is higher than 91.86% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $808.00M | +1.5% | +7.5% | -8.3% | +51.0% | |
| Annual EBITDA | $761.20M | – | +1.5% | -13.9% | +44.1% | |
| Quarterly EBITDA | $223.30M | +3.0% | +5.7% | +15.8% | +48.1% | |
| Price | $231.09 | -13.6% | +3.1% | -26.5% | -15.7% | |
| PE Ratio | 34.02 | -14.2% | +1.5% | -16.4% | -43.3% | |
| TTM Revenue | $3.07B | +1.9% | +6.3% | +6.5% | +43.2% | |
| TTM EPS | $6.79 | +0.6% | +1.6% | -12.1% | +48.6% | |
| $617.40M | -2.1% | +3.6% | -18.8% | +46.4% | ||
| TTM Net Income | $493.70M | +0.4% | +0.2% | -15.7% | +42.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $808.00M | at high | |
| 3Y | $880.70M | N/A | -8.3% |
| 5Y | $903.10M | -10.5% | |
| All | $903.10M | -10.5% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $751.60M | N/A | +7.5% |
| 3Y | $746.80M | +8.2% | |
| 5Y | $535.00M | N/A | +51.0% |
| All | -$171.90M | +570.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of WST?
As of today, WST TTM EBITDA is $808.00M
What is WST TTM EBITDA most recent change?
WST TTM EBITDA was up +1.51% on December 31, 2025
What is 1-year change in WST TTM EBITDA?
WST TTM EBITDA is up +7.50% year-over-year
How far is WST TTM EBITDA from its all-time high?
WST TTM EBITDA is currently -10.53% below its historical high of $903.10M set on September 30, 2022
How does WST TTM EBITDA rank versus sector peers?
WST TTM EBITDA is higher than 91.86% of companies in Healthcare sector
When is WST next earnings release?
The next earnings release for WST is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- WST Official Website www.westpharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/105770/000010577026000010/0000105770-26-000010-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/105770/000010577026000010/0000105770-26-000010-index.htm
- WST Profile on Yahoo Finance finance.yahoo.com/quote/WST
- WST Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/wst